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There is usually a large number of particles in the environmental air. During breathing, they 
may irritate the epithelial tissue of the airways, causing inflammatory processes which might 
induce asthma, emphysema or COPD (chronic obstructive pulmonary disease). By breathing, 
biologically active, toxic or carcinogenic chemicals may be incorporated into the body as a 
result of particle deposition. Near half of the ionizing radiation burden originates from the 
inhalation, airway deposition and decay of radon progenies. 222Rn first decays into 218Po with a 
half-life of 3.8 days by alpha radiation, which decays again by alpha radiation into 214Pb with a 
half-life of 3.1 minutes. Then after a beta decay 214Bi is formed (half-life 26.8 min), and after 
another beta decay (half-life 19.7 min) one get 214Po which emits another alpha particle (with a 
half-life of 164μs). 
A number of epidemiological studies (ICRP 66, BEIR VI, UNSCEAR 2009) demonstrate 
a strong correlation between the activity concentration of radon in dwellings and the probability 
of lung cancer development. 
Therefore it can be stated, that a significant part of environmental hazards are related to 
respiration. 
It is important both for physics, medicine and biology to examine the biological effect of 
inhaled particles. Here the first step can be the determination of airway deposition distribution. 
The deposition distribution can be tested experimentally by gamma camera or SPECT 
(Single Photon Emission Computer Tomography) after inhalation of radiolabelled particles. 
However, these methods have many disadvantages and difficulties. The main problem is the 
resolution of the experimental procedures. These methods are not suitable for examining the 
small airways below the diameter of 2 mm. 
The deposition distribution of inhaled particles can be calculated by numerical 
procedures, such as in silico lung models. 
The main advantages of lung models are that they are flexible, the simulations can be 
reproduced, and their cost is usually much lower than the cost of experimental procedures. 
The so-called Stochastic Lung Model is used to simulate the respiratory deposition 
distribution of the inhaled particles. This software can be applied to determine the deposition 
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distribution of aerosols between the regions of the breathing system with a uniquely fine airway 
generation related resolution. 
During my doctoral work I have applied and developed this model in many areas. 
 
2. Objectives 
During my doctoral work, I set the following objectives: 
 
A. The development of the Stochastic Lung Model to make it suitable for the description of 
deposition density of particles along the airways. 
B. The further development and application of the model, that it be more suitable for the 
quantification of the airway deposition distribution of inhaled aerosol drugs. 
C. The further development and application of the model, that it be more suitable for the 
simulation of deposition distribution of inhaled particles in diseased airway system with 
asthma, emphysema and COPD. 
D. The further development and application of the model, that it be more suitable for the 
description of the activity distributions and cell nucleus dose distributions of inhaled and 
deposited radon progenies along the bronchial airways. 
E. To create and apply a bronchial mucociliary clearance model to simulate the effect of 
mucociliary clearance on activity and cell nucleus dose distributions of deposited radon 
progenies. 
 
3. Applied Methods 
I have modified and enhanced the source code of the Stochastic Lung Model, making it more 
flexible and more realistic. The most important types of the development were the followings: 
(i) the development of an algorithm for the computation of the surface of the airways, 
(ii) the computation of deposition densities along the airway generations, 
(iii) the simulation of the trajectories of hygroscopic particles, 
(iv) the numerical description and characterisation of asthmatic and emphysematic lungs, 
(v) the simulation of inspiratory waveform in the model, 
(vi) the simulation of activity and cell nucleus dose distributions originating from radon 
progenies considering both primary deposition and mucociliary clearance. 
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4. New scientific results achieved during the research: 
A) Characterization of the deposition distributions of ultrafine 
urban aerosols 
For the prediction of the biological effect of inhaled particles, it is not enough to analyse the 
deposition distribution of inhaled particles in the respiratory system, but the quantification of 
the distribution of deposition density (deposition on unit surface) is also needed. 
At the examination of airway deposition of ultrafine urban aerosols I have demonstrated 
that the extrathoracic deposition fraction by the increase of physical activity decreased from 
26% to 9%. The tracheobronchial deposition fraction was not sensitive to physical activity and 
was on average 12.5%. The acinar deposition fraction increased strongly with physical activity 
from 14.7% to 34%. Regarding the whole respiratory tract, the deposition fraction always has 
a significant peak in the acinar region. By physical activity, this peak moves deeper into the 
lungs. The number-deposition density distribution is quite different compared to the distribution 
of the deposition fractions and indicates that the largest surface load within the lungs is in the 
first few airway generations, i.e. in the large central airways. Based on the literature data, this 
region is where most of the lung cancer cases can be found (Cross 1987). This confirms the 
assumption that the biological effect is better described by the deposition density distribution 
than the deposition fractions. Some of the relevant results are shown in Figures 1 and 2. 
 
 
Figure 1: Bronchial and acinar airway deposition fraction distributions of ultrafine urban 




Figure 2: Airway deposition density distributions (bronchial + acinar) of ultrafine urban 
aerosols for woman performing sleeping and light exercise physical activity breathing 
conditions, location Budapest Astoria site 
 
B) Description of airway deposition distributions of an 
industrial aerosol in healthy and diseased lungs 
I studied the effect of the modified airway geometry and breathing pattern due to respiratory 
diseases (asthma, emphysema, silicosis) on the airway deposition distributions applying the size 
distribution of an Egyptian industrial aerosol. In case of heavily diseased breathing system with 
bronchitis and bullous emphysema, acinar deposition is greatly increased compared to the 
healthy lung. During mouth breathing the difference is even bigger. Based on the results, it can 
be stated that for workers with obstructive or restrictive respiratory illnesses, or healthy workers 
with mouth breathing, it is highly unhealthy to work in such heavily polluted area. If the first 
symptoms of a respiratory tract illness are recognized, the worker should stop working in the 
polluted area or his illness will become more and more serious. Figures 3 shows a few of the 
specific cases of the deposition fraction distributions (Figure 3 left panel) and the deposition 
density distributions (Figure 3 right panel) in the lungs of healthy and diseased (panacinar and 





    
Figure 3: Mass deposition fraction distributions and mass deposition density distributions as a 
function of airway generation number in healthy and diseased lungs during mouth breathing 
 
C) Simulation of airway deposition distributions of aerosol 
medicines in diseased respiratory systems 
For the description of the airway deposition distributions of aerosol drugs, I have developed a 
new version of the Stochastic Lung Model, which is suitable in all respects for the determination 
of the parameter values required for individualized medicine selection. 
Based on a series of inhalational experiments performed with volunteers, it can be stated 
that the deposition distribution in the respiratory system strongly depends on the particle size 
distribution of the drug, the type of the applied inhaler and the patient's individual spirometric 
data (Figure 4). 
 
Figure 4: Regional mass deposition fraction distribution of the therapeutic aerosol emitted 
from the Symbicort Turbuhaler inhalator in the cases of 15 volunteers 
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Applying my developments in the lung model, a new method have been elaborated by 
our group which takes the individualized medicine selection possible, based on our knowledge 
first time in the world. For the enhancement of the efficiency of the therapy, it is highly 
advantageous for the patient to select the most suitable inhaler and in this drug selection 
procedure the Stochastic Lung Model has a unique role. 
 
D) Determination of the effect of mucociliary clearance on the 
activity distribution of inhaled radon progenies 
For the description of the effect of mucociliary clearance on the activity distribution of inhaled 
radon progenies along the bronchial airway generations I have developed a numerical model 
and built in into the Stochastic Lung Model. This version of the Model can follow the airway 
trajectories and radioactive decays of the 218Po, 214Po, 214Bi, 214Pb isotopes. Based on my results, 
it can be stated that in the large bronchial airways the alpha activity of 214Po isotope cleared up 
from the deeper airway generations is higher than the alpha activity of 218Po plus 214Po isotopes 
decayed in the same airway generation where they were deposited. That is, the role of clearance 
is very important. For this type of analysis, a lung model with at least airway generation 
resolution is required. 
The nowadays widely used lung model in radiation protection, the Human Respiratory 
Tract Model (HRTM) divides the tracheobronchial region only into two, large bronchial (BB) 
and bronchiolar (bb) regions. Due to its limited resolution, this model is not suitable for the 
characterization of the effect of mucociliary clearance in the tracheobronchial region. To 
characterize the biological effect, a more complex model with at least airway generation related 
resolution is needed, such as the Radact version of the Stochastic Lung Model. 
 
E) Quantification of absorbed cell nucleus doses originating 
from deposition and clearance of inhaled radon progenies 
The absorbed doses originating from the alpha decays of inhaled radon progenies are strongly 
inhomogeneous along the bronchial region of the respiratory system. Supposing the global 
average home microenvironment, the average absorbed cell nucleus dose intensities vary 
between 10-13 Gy/hour and 10-7 Gy/hour for a healthy adult man along the bronchial airway 
generations. The maximum average absorbed cell nucleus dose intensities can be found 
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between the first and fourth airway generations. Most of the lung cancer cases based on clinical 
experience (Cross 1987) are developed in this region of the lung. The lung model widely used 
by radiation protection (HRTM, ICRP 1994) is not able to detect inhomogenity within the large 
and small bronchial airways, thereby this model is probably not able to adequately estimate the 
biological effect of inhaled radon progenies. Figure 5 and 6 depicts the cell nucleus dose rate 
distributions in the sensitive epithelial cells of the bronchial region originating from the 
unattached and attached progenies as a function of bronchial airway generation number in the 
global average home environment. 
 
Figure 5. Cell nucleus dose rate distributions along the bronchial airways in the sensitive cells 
of the epithelium originating from the first (left panel) and second (right panel) alpha decay of 
unattached 218Po, by computing the deposition and clearance components, healthy sitting man 
 
Figure 6. Absorbed cell nucleus dose rate distributions along the bronchial airways originating 
from the alpha decay of attached 218Po (left panel) and the 214Po alpha decay of all the 
attached particles (218Po,214Pb, 214Bi) (right panel), at healthy sitting man  
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